CT增强碘对比剂急性不良反应发生及影响因素分析

来源期刊：广州医药 | 829-835 发布时间：2025-07-23 收稿时间：2025/11/13 18:53:23 阅读量：15

作者：: 崔群,

杜维,

张少柯,

刘通,

费灵芝,

关键词：: CT增强碘对比剂急性不良反应影响因素过敏史肾功能不全; CT enhancement iodine contrast agent acute adverse reactions influencing factors allergy history renal insufficiency

DOI：: 10.20223/j.cnki.1000-8535.2025.06.017

收稿时间：: 2024-06-12
修订日期：
接收日期：
引用总数：: 0

目的探讨电子计算机断层扫描（CT）增强碘对比剂急性不良反应发生及影响因素分析。方法选取天津市肿瘤医院空港医院2020年10月—2023年10月收治的100例行CT增强出现碘对比剂急性不良反应的患者进行回顾性分析,将其分为观察组,另选取同期在我院行CT增强检查未发生不良反应的100例患者作为对照组。分析观察组患者碘对比剂急性不良反应情况,对比两组患者临床资料及碘对比剂注射情况,以急性不良反应作为因变量（发生急性不良反应=1,未发生急性不良反应=0）纳入Logistic回归模型,分析CT增强碘对比剂急性不良反应发生的独立影响因素。结果 100例发生碘对比剂急性不良反应的患者中轻度65例（65.00%）,中度34例（34.00%）,重度1例（1.00%）;观察组与对照组性别、年龄、体质指数（BMI）、高血压史、糖尿病史、心功能不全史、甲状腺功能亢进史、冠状动脉粥样硬化性心脏病史、碘对比剂使用史、食物过敏史对比差异无统计学意义（P>0.05）,观察组与对照组哮喘史（9.00% vs 2.00%）、肾功能不全史（13.00% vs 3.00%）、碘对比剂不良反应发生史（21.00 % vs 2.00%）、花粉过敏史（12.00% vs 4.00%）、药物过敏史（26.00% vs 7.00%）及其他过敏史（10.00 % vs 2.00%）,对比差异有统计学意义（χ²=4.710,P=0.030;χ²=6.790,P=0.009;χ²=17.740,P<0.001;χ²=4.350,P=0.037;χ²=13.100,P<0.001;χ²=5.670,P=0.017）;观察组与对照组碘对比剂剂量对比差异无统计学意义（P>0.05）,观察组与对照组碘对比剂注射速度（<3 mL/min为55.00% vs 69.00%;≥3 mL/min为45.00% vs 31.00%）、碘对比剂类型（碘克沙醇为34.00% vs 34.00%,碘佛醇为47.00% vs 30.00%,碘海醇为19.00% vs 36.00%）对比差异有统计学意义（χ²=4.160,P=0.041;χ²=9.010,P=0.011）;肾功能不全史、碘对比剂不良反应发生史、药物过敏史、其他过敏史、碘对比剂注射速度为发生碘对比剂急性不良反应的影响因素（P<0.05）。结论 CT增强碘对比剂急性不良反应多以轻度为主,且以往合并肾功能不全、碘对比剂不良反应发生史、药物过敏史、其他过敏史、碘对比剂注射速度过高可能为碘对比剂不良反应发生的影响因素。

Objective To explore the occurrence and influencing factors of acute adverse reactions of iodine contrast agents in enhanced computed tomography（CT）. Methods A retrospective analysis was conducted on 100 patients admitted to our hospital from October 2020 to October 2023 who experienced acute adverse reactions to iodine contrast agents during CT enhancement．They were divided into an observation group and another 100 patients who underwent CT enhancement examination in our hospital during the same period without any adverse reactions were selected as the control group．The acute adverse reactions of iodine contrast agent in the observation group of patients were analyzed,the clinical data and injection of iodine contrast agent between the two groups of patients were compared,and include acute adverse reactions as the dependent variable（occurrence of acute adverse reactions=1,absence of acute adverse reactions=0）was used in the Logistic regression model to analyze the independent influencing factors of acute adverse reactions of CT enhanced iodine contrast agent．Results Among the 100 patients who experienced acute adverse reactions to iodine contrast agents,65 were mild reactions,accounting for 65.00%,34 cases had were moderate reactions,accounting for 34.00%,and one cases had severe reactions,accounting for 1.00%．There was no significant difference between the observation group and the control group in gender,age,body mass index（BMI）,history of hypertension,diabetes,heart dysfunction,hyperthyroidism,coronary heart disease,use of iodine contrast agent,and food allergy（P>0.05）．The history of asthma（9.00% vs 2.00%）,renal insufficiency（13.00% vs 3.00%）,adverse reactions of iodine contrast（21.00 % vs 2.00%）,pollen allergy（12.00% vs 4.00%）,drug allergy（26.00% vs 7.00%）and other allergies（10.00 % vs 2.00%）were significantly different（χ²=4.710,P=0.030;χ²=6.790,P=0.009;χ²=17.740,P<0.001;χ²=4.350,P=0.037;χ²=13.100,P<0.001;χ²=5.670,P=0.017）．There was no significant difference in the dosage of iodine contrast agent between the observation group and the control group（P>0.05）．The injection rate of iodine contrast agent between the observation group and the control group（< 3 mL/min was 55.00% vs 69.00%;≥3 mL/min was 45.00% vs 31.00%）,and the types of iodoxanol （iodoxanol[34.00% vs 34.00%],iodoxanol[47.00% vs 30.00%],iodohexanol[19.00% vs 36.00%]） were significantly different（χ²=4.160,P=0.041;χ²=9.010,P=0.011）．History of renal insufficiency,adverse reactions to iodine contrast agents,drug allergies,other allergies,and injection speed of iodine contrast agents were independent risk factors for the occurrence of acute adverse reactions to iodine contrast agents（P<0.05）．Conclusions Acute adverse reactions to iodinated contrast agents in CT enhancement are mostly mild．Previous history of renal insufficiency,history of adverse reactions to iodinated contrast agents,history of drug allergies,other allergic histories,and high injection speed of iodinated contrast agents may be influencing factors for the occurrence of adverse reactions to iodinated contrast agents．

1、 WALKER H,GUTHRIE G D,LAMBOURG E,et al.Systematic review and meta-analysis of prophylaxis use with intravenous contrast exposure to prevent contrast-induced nephropathy[J].Eur J Radiol,2022(153):110368.

2、徐元杰,张晶,王茹,等.碘对比剂不良反应报告分析[J].中国医学影像学杂志,2020,28(3):232-235.

3、杨涵,吴跃辉,向欣,等.碘克沙醇致全脑血管造影术后对比剂脑病一例并文献复习[J].中国脑血管病杂志,2022,19(3):198-201.

4、 UMAKOSHI H,NIHASHI T,TAKADA A,et al.Iodinated contrast media substitution to prevent recurrent hypersensitivity reactions:A systematic review and meta-analysis[J].Radiology,2022,305(2):341-349.

5、 DIEN ESQUIVEL M F,MILLER E,BIJELI? V,et al.CT contrast extravasation in children:A single-center experience and systematic review[J].Pediatr Radiol,2024,54(1):34-42.

6、孙存娟,阚宏,童敏,等.碘对比剂恒温箱加热对CT增强扫描不良反应、检查舒适度和图像质量的影响[J].川北医学院学报,2022,37(7):943-946.

7、唐碧雨,吴建茹,魏芬芳,等.基于自发呈报系统的碘对比剂不良反应数据挖掘[J].中国药房,2022,33(17):2129-2132.

8、朱传明,郑晓风,侯杰,等.碘对比剂急性不良反应回顾性分析[J].医学影像学杂志,2022,32(12):2155-2158.

9、章爱华,高文霞,姚世文.心脏CT血管成像中碘对比剂浓度对肥胖病人冠状动脉检查图像质量、肾功能及碘用量的影响[J].安徽医药,2023,27(9):1800-1803.

10、 WOOLEN S A,SHANKAR P R,GAGNIER J J,et al.Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent:A systematic review and meta-analysis[J].JAMA Intern Med,2020,180(2):223-230.

11、周晓丹,冯国纹,黎丹,等.基于FAERS数据库的碘对比剂不良反应信号挖掘及危险因素分析[J].临床放射学杂志,2023,42(4):683-691.

12、许伟,刘艳.CT增强检查中碘对比剂急性不良反应与焦虑状态的相关性[J].中南大学学报(医学版),2023,48(8):1225-1233.

13、贾春艳,邓宁静,梁平,等.肿瘤病人碘对比剂急性不良反应33例分析[J].安徽医药,2023,27(12):2542-2544.

14、宋卉,曾超,廖凯,等.心脑血管病患者CT增强检查中非离子型碘对比剂相关急性不良反应预测模型的构建[J].中国CT和MRI杂志,2024,22(4):13-16.

15、邱海燕,王羚入,李建洁,等.332683例CT增强检查患者非离子碘对比剂急性不良反应情况及其影响因素分析[J].陆军军医大学学报,2023,45(3):257-264.

16、 HSIEH C,WU S C,KOSIK R O,et al.Pharmacological prevention of hypersensitivity reactions caused by iodinated contrast media:A systematic review and meta-analysis[J].Diagnostics,2022 ,12(7):1673.

17、杨秋月,汪晖,李琴,等.CT增强碘对比剂急性不良反应发生现况及影响因素[J].护理研究,2023,37(12):2122-2129.

18、 ONG M Y,KOH J J,KOTHAN S,et al.The incidence and associated risk factors of contrast-induced nephropathy after contrast-enhanced computed tomography in the emergency setting:A systematic review[J].Life,2022 ,12(6):826.

19、 KUTLE?A Z,JERKOVI? K,ORDULJ I,et al.The effect of contrast media on CT measures of bone mineral density:A systematic review[J].Skeletal Radiol,2023,52(4):687-694.

20、 HAGELBERG J,PAPE B,HEIKKINEN J,et al.Diagnostic accuracy of contrast-enhanced CT for neck abscesses:A systematic review and meta-analysis of positive predictive value[J].PLoS One,2022 ,17(10):e0276544.

21、周婷,王刚.64排螺旋CT双低剂量技术应用于肺动脉CTA的价值[J].现代医院,2020,20(4):622-624.

22、中华医学会放射学分会对比剂安全使用工作组.碘对比剂使用指南(第2版)[J].中华医学杂志,2014,94(43):3363-3369.

23、邢腾龙,邢炳伟,解丙坤,等.碘对比剂不良反应与心脑血管狭窄程度的相关性分析[J].中国CT和MRI杂志,2023,21(1):36-37.

24、 KOEPPEL D R,BOEHM I B.Shortage of iodinated contrast media:Status and possible chances - A systematic review[J].Eur J Radiol,2023(164):110853.

25、 van der POL C B,MCINNES M D F,SALAMEH J P,et al.CT/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma:Individual patient data meta-analysis[J].Radiology,2023,307(1):e239005.